Back to Search Start Over

Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient Survey

Authors :
M Warm
A. Sauerwald
Julian Puppe
M. Najafpour
Charles M. Eichler
Source :
BioMed Research International, BioMed Research International, Vol 2015 (2015)
Publication Year :
2015
Publisher :
Hindawi Publishing Corporation, 2015.

Abstract

Introduction. Platelet-rich plasma (PRP) is a product widely used in sports medicine, tissue repair, and general surgery. A recent meta-analysis showed this product to be beneficial when introduced into a wound area, be it intra-articular (i.e., joint-injections) or direct introduction onto the wound surface.Methods. Between the years of 2012 and 2014 a questionnaire evaluating surgical outcome after port (venous access device) removal was answered by 100 patients in the control group and 20 patients in a PRP group, leading to a total of 120 patients in this single center, retrospective, subjective outcome evaluation.Results. No statistical difference was shown in postsurgical complication rates, postsurgical pain, decreased mobility, and overall quality of life. A significant difference was shown in overall patient satisfaction and the desire to further improve port area scarring. Results differed significantly in favor of the PRP group. Interestingly, approximately 40.2% of patients are dissatisfied with the surgical outcome after port removal in the control group. This result, though surprising, may be improved to 10% dissatisfaction when a PRP product is used.Conclusion. PRP products such as Arthrex ACP are safe to use and present an additional option in improving surgical outcome.

Details

Language :
English
ISSN :
23146133
Database :
OpenAIRE
Journal :
BioMed Research International
Accession number :
edsair.doi.dedup.....1752d689212f597c01afb76f8e81e66d
Full Text :
https://doi.org/10.1155/2015/630601